Evidence map›Paper›PMID 32484994›Full record

ArticleThe EMBO journal2020

NR2F1 regulates regional progenitor dynamics in the mouse neocortex and cortical gyrification in BBSOAS patients.

Michele Bertacchi, Anna Lisa Romano, Agnès Loubat, Frederic Tran Mau-Them, Marjolaine Willems, Laurence Faivre, Philippe Khau van Kien, Laurence Perrin, Françoise Devillard, Arthur Sorlin and 10 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. CRL4EMBO reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Michele BertacchiUniversité Côte d'Azur, CNRS, Inserm, iBV, Paris, France.ORCID 0000-0002-4402-4974
Anna Lisa RomanoUniversité Côte d'Azur, CNRS, Inserm, iBV, Paris, France.
Agnès LoubatUniversité Côte d'Azur, CNRS, Inserm, iBV, Paris, France.
Frederic Tran Mau-ThemUMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Marjolaine WillemsHôpital Arnaud de Villeneuve, Service de Génétique Médicale, CHU de Montpellier, Montpellier, France.
Laurence FaivreUMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Philippe Khau van KienHôpital Carémeau, UF de Génétique Médicale et Cytogénétique, Centre de Compétences Anomalies du Développement et Syndromes Malformatifs, CHU de Nîmes, Nîmes, France.
Laurence PerrinUnité Fonctionnelle de Génétique Clinique, Hôpital Robert Debré, Paris, France.
Françoise DevillardDépartement de Génétique et Procréation, Hôpital Couple-Enfant, CHU de Grenoble, Grenoble, France.
Arthur SorlinUMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Paul KuentzUMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.ORCID 0000-0003-2814-6303
Christophe PhilippeUMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.
Aurore GardeUnité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Francesco NeriEpigenetics Unit, Italian Institute for Genomic Medicine, University of Torino, Torino, Italy.
Rossella Di GiaimoDepartment of Biology, University of Naples Federico II, Napoli, Italy.ORCID 0000-0003-3604-3697
Salvatore OlivieroEpigenetics Unit, Italian Institute for Genomic Medicine, University of Torino, Torino, Italy.
Silvia CappelloMax Planck Institute of Psychiatry, München, Germany.ORCID 0000-0003-4539-9038
Ludovico D'IncertiNeuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Carolina FrassoniClinical and Experimental Epileptology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Michèle StuderUniversité Côte d'Azur, CNRS, Inserm, iBV, Paris, France.ORCID 0000-0001-7105-2957
Inserm · FRCentre National de la Recherche Scientifique · FRFondazione IRCCS Istituto Neurologico Carlo Besta · ITItalian institute for Genomic Medicine · ITMax Planck Institute of Psychiatry · DECentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Nîmes · FRCHU Dijon Bourgogne · FRHôpital Arnaud de Villeneuve · FRHôpital Robert-Debré · FR

Funding

Agence Nationale de la Recherche (ANR) ANR-11-LABX-0028-01Agence Nationale de la Recherche (ANR) ANR-15-NEUR-0002-04European Molecular Biology Organization (EMBO) STF#8035Fondation Jérôme Lejeune 199162Ville de Nice - Aides Individuelles aux Jeunes Chercheurs
6 · The paper itself

Abstract

The relationships between impaired cortical development and consequent malformations in neurodevelopmental disorders, as well as the genes implicated in these processes, are not fully elucidated to date. In this study, we report six novel cases of patients affected by BBSOAS (Boonstra-Bosch-Schaff optic atrophy syndrome), a newly emerging rare neurodevelopmental disorder, caused by loss-of-function mutations of the transcriptional regulator NR2F1. Young patients with NR2F1 haploinsufficiency display mild to moderate intellectual disability and show reproducible polymicrogyria-like brain malformations in the parietal and occipital cortex. Using a recently established BBSOAS mouse model, we found that Nr2f1 regionally controls long-term self-renewal of neural progenitor cells via modulation of cell cycle genes and key cortical development master genes, such as Pax6. In the human fetal cortex, distinct NR2F1 expression levels encompass gyri and sulci and correlate with local degrees of neurogenic activity. In addition, reduced NR2F1 levels in cerebral organoids affect neurogenesis and PAX6 expression. We propose NR2F1 as an area-specific regulator of mouse and human brain morphology and a novel causative gene of abnormal gyrification.

Indexed as

AnimalsCOUP Transcription Factor IDisease Models, AnimalHumansMiceNeocortexNeural Stem CellsOccipital LobeOptic Atrophies, HereditaryParietal LobePAX6 Transcription FactorCOUP Transcription Factor INR2F1 protein, humanNr2f1 protein, mousePAX6 protein, humanPax6 protein, mousePAX6 Transcription FactorBBSOAScell cycle dynamicscortical foldingneurodevelopmental diseaseNR2F1/COUP-TFI

Identifiers

PMID32484994
PMCPMC7327499
OpenAlexW3032314173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.